Cargando…
Light-Triggered Cellular Delivery of Oligonucleotides
The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approache...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410276/ https://www.ncbi.nlm.nih.gov/pubmed/30795565 http://dx.doi.org/10.3390/pharmaceutics11020090 |
_version_ | 1783402210167619584 |
---|---|
author | Kontturi, Leena-Stiina van den Dikkenberg, Joep Urtti, Arto Hennink, Wim E. Mastrobattista, Enrico |
author_facet | Kontturi, Leena-Stiina van den Dikkenberg, Joep Urtti, Arto Hennink, Wim E. Mastrobattista, Enrico |
author_sort | Kontturi, Leena-Stiina |
collection | PubMed |
description | The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approached this challenge by developing a light-triggered liposomal delivery system for oligonucleotides based on a non-cationic and thermosensitive liposome with indocyanine green (ICG) as photosensitizer. The liposomes had efficient release properties, as 90% of the encapsulated oligonucleotides were released after 1-minute light exposure. Cell studies using an enhanced green fluorescent protein (EGFP)-based splicing assay with HeLa cells showed light-activated transfection with up to 70%–80% efficacy. Moreover, free ICG and oligonucleotides in solution transfected cells upon light induction with similar efficacy as the liposomal system. The light-triggered delivery induced moderate cytotoxicity (25%–35% reduction in cell viability) 1–2 days after transfection, but the cell growth returned to control levels in 4 days. In conclusion, the ICG-based light-triggered delivery is a promising method for oligonucleotides, and it can be used as a platform for further optimization and development. |
format | Online Article Text |
id | pubmed-6410276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-64102762019-03-29 Light-Triggered Cellular Delivery of Oligonucleotides Kontturi, Leena-Stiina van den Dikkenberg, Joep Urtti, Arto Hennink, Wim E. Mastrobattista, Enrico Pharmaceutics Article The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and stable in vivo, but interact with the target cells and release the loaded oligonucleotides intracellularly. We approached this challenge by developing a light-triggered liposomal delivery system for oligonucleotides based on a non-cationic and thermosensitive liposome with indocyanine green (ICG) as photosensitizer. The liposomes had efficient release properties, as 90% of the encapsulated oligonucleotides were released after 1-minute light exposure. Cell studies using an enhanced green fluorescent protein (EGFP)-based splicing assay with HeLa cells showed light-activated transfection with up to 70%–80% efficacy. Moreover, free ICG and oligonucleotides in solution transfected cells upon light induction with similar efficacy as the liposomal system. The light-triggered delivery induced moderate cytotoxicity (25%–35% reduction in cell viability) 1–2 days after transfection, but the cell growth returned to control levels in 4 days. In conclusion, the ICG-based light-triggered delivery is a promising method for oligonucleotides, and it can be used as a platform for further optimization and development. MDPI 2019-02-21 /pmc/articles/PMC6410276/ /pubmed/30795565 http://dx.doi.org/10.3390/pharmaceutics11020090 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kontturi, Leena-Stiina van den Dikkenberg, Joep Urtti, Arto Hennink, Wim E. Mastrobattista, Enrico Light-Triggered Cellular Delivery of Oligonucleotides |
title | Light-Triggered Cellular Delivery of Oligonucleotides |
title_full | Light-Triggered Cellular Delivery of Oligonucleotides |
title_fullStr | Light-Triggered Cellular Delivery of Oligonucleotides |
title_full_unstemmed | Light-Triggered Cellular Delivery of Oligonucleotides |
title_short | Light-Triggered Cellular Delivery of Oligonucleotides |
title_sort | light-triggered cellular delivery of oligonucleotides |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410276/ https://www.ncbi.nlm.nih.gov/pubmed/30795565 http://dx.doi.org/10.3390/pharmaceutics11020090 |
work_keys_str_mv | AT kontturileenastiina lighttriggeredcellulardeliveryofoligonucleotides AT vandendikkenbergjoep lighttriggeredcellulardeliveryofoligonucleotides AT urttiarto lighttriggeredcellulardeliveryofoligonucleotides AT henninkwime lighttriggeredcellulardeliveryofoligonucleotides AT mastrobattistaenrico lighttriggeredcellulardeliveryofoligonucleotides |